- Home
- CB vs SYK Comparison
CB vs SYK Comparison
Compare CB & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CB | SYK |
|---|---|---|
| Founded | 1985 | 1941 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.9B | 120.4B |
| IPO Year | 1995 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CB | SYK |
|---|---|---|
| Price | $340.55 | $331.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 14 |
| Target Price | $332.76 | ★ $415.57 |
| AVG Volume (30 Days) | 1.5M | ★ 2.3M |
| Earning Date | 04-21-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.19% | 1.12% |
| EPS Growth | ★ 13.13 | 8.25 |
| EPS | ★ 5.88 | 1.93 |
| Revenue | ★ $59,402,000,000.00 | $25,116,000,000.00 |
| Revenue This Year | N/A | $9.80 |
| Revenue Next Year | $5.31 | $8.44 |
| P/E Ratio | ★ $56.29 | $163.91 |
| Revenue Growth | 6.54 | ★ 11.16 |
| 52 Week Low | $264.10 | $281.00 |
| 52 Week High | $345.67 | $404.87 |
Technical Indicators
Market Signals| Indicator | CB | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 64.88 | 64.05 |
| Support Level | $317.41 | $323.77 |
| Resistance Level | $345.67 | $375.26 |
| Average True Range (ATR) | 6.70 | 8.72 |
| MACD | 1.56 | 2.50 |
| Stochastic Oscillator | 99.43 | 94.80 |
Price Performance
Historical ComparisonAbout CB Chubb Limited
ACE acquired Chubb in 2016 and assumed the Chubb name. The combination made the new Chubb one of the largest domestic property and casualty insurers, with operations in over 50 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.